or Try an Advanced Search...

    Technical Analysis for SRRK - Scholar Rock Holding Corporation

    Grade Last Price % Change Price Change
    B 27.86 0.00% 0.00
    SRRK closed unchanged on Wednesday, November 20, 2024, on 34 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical SRRK trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Doji - Bullish? Reversal 5.61%
    Stochastic Reached Oversold Weakness 5.61%
    Lower Bollinger Band Touch Weakness 5.61%
    Oversold Stochastic Weakness 5.61%
    BB Squeeze Ended Range Expansion 1.31%
    1,2,3 Pullback Bullish Bullish Swing Setup 1.75%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 1.75%
    Bollinger Band Squeeze Range Contraction 1.75%
    Lower Bollinger Band Walk Weakness 1.75%
    Older End-of-Day Signals for SRRK ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 20 hours ago
    Up 1% about 21 hours ago
    60 Minute Opening Range Breakout about 22 hours ago
    10 DMA Support about 24 hours ago
    Down 1% about 24 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    SRRK Chart by TradingView
    Basic chart:

    Profile

    Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Natural Sciences Medication Anemia Fibrosis Neuromuscular Disorders

    Is SRRK a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 13 Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Highlights: Strategic Advances and ...
    Nov 12 Scholar Rock Holding Corporation (SRRK) Q3 2024 Earnings Call Transcript
    Nov 12 Scholar Rock GAAP EPS of -$0.66 misses by $0.06
    Nov 12 Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress
    Nov 12 Earnings Scheduled For November 12, 2024
    Nov 4 Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin
    Nov 1 Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024
    Oct 31 Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting
    Oct 25 Top 2 Health Care Stocks That May Fall Off A Cliff This Month
    Oct 22 Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering
    See more SRRK news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 35.3799
    52 Week Low 6.76
    Average Volume 2,281,122
    200-Day Moving Average 14.38
    50-Day Moving Average 21.73
    20-Day Moving Average 28.47
    10-Day Moving Average 27.63
    Average True Range 1.75
    RSI (14) 55.75
    ADX 31.24
    +DI 30.12
    -DI 19.26
    Chandelier Exit (Long, 3 ATRs) 25.98
    Chandelier Exit (Short, 3 ATRs) 31.01
    Upper Bollinger Bands 30.99
    Lower Bollinger Band 25.95
    Percent B (%b) 0.38
    BandWidth 17.69
    MACD Line 1.06
    MACD Signal Line 1.74
    MACD Histogram -0.6797
    Fundamentals Value
    Market Cap 2.01 Billion
    Num Shares 72.1 Million
    EPS -1.95
    Price-to-Earnings (P/E) Ratio -14.29
    Price-to-Sales 11.33
    Price-to-Book 6.63
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 29.28
    Resistance 3 (R3) 29.27 28.78 29.04
    Resistance 2 (R2) 28.78 28.42 28.79 28.96
    Resistance 1 (R1) 28.32 28.20 28.08 28.33 28.88
    Pivot Point 27.84 27.84 27.72 27.84 27.84
    Support 1 (S1) 27.38 27.48 27.14 27.39 26.84
    Support 2 (S2) 26.89 27.25 26.90 26.76
    Support 3 (S3) 26.43 26.89 26.68
    Support 4 (S4) 26.44